Important: New Login Process

We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.

  • If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
  • If you log in with a username and password, you will be prompted to set a new password before accessing your account.

Go to the Login Page to get started.

We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.

BioCentury
  • Company Profiles
  • Target Profiles
  • Product Profiles
Explore BCIQ profiles by entering a company name.

Theras Inc. (Bridgebio Oncology Therapeutics)

Headquarters: South San Francisco, CA, United States of America
Year Founded: 2016
Status: Private

BioCentury | Mar 4, 2025
Deals

Kyorin picks Novartis amid innovative push; Abbvie taps Gubra for obesity: Deals Report

Plus: Hummingbird/Callio, Bridgene/Takeda, Magnet/Lilly, Gensaic/Novo, and more
BioCentury | Sep 10, 2024
Management Tracks

Lucas Montarce named Lilly CFO 

Plus: Yong Ben hired as chief medical and development officer of TheRas, and updates from Orbital, Latigo, AAVantgarde and more
BioCentury | Aug 22, 2024
Finance

Venture Report: Megarounds for BridgeBio newco, Pathalys and the latest from Versant

$300M raise for rare disease company GondolaBio headlines the week’s biggest venture rounds
BioCentury | May 2, 2024
Finance

Venture report: Rounds for psychedelic play Reunion, cancer company Delphia

Plus: Syndicate backs BridgeBio’s cancer spinout, AbCellera teams with investors to form asset-focused newcos, and more
Items per page:
1 - 4 of 4
Help Center
Username
Request a Demo
Request Training
Ask a Question